Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| SBGISinclair, Inc. | $997.99M | 17.9× | $3.17B | -10.7% | -$112M | $604M | $4.17B | Fair valued |
| CSTLCastle Biosciences Inc | $998.97M | — | $344.23M | +3.7% | -$24.16M | $62.12M | $36.65M | Fair valued |
| SMPLSimply Good Foods Co | $1.01B | — | $1.45B | +9.0% | $103.61M | $123.88M | $448.46M | Undervalued |
| HPKHighPeak Energy, Inc. | $1.01B | — | $863.36M | -22.7% | $18.96M | $146.35M | $1.19B | Fair valued |
| TTITetra Technologies Inc | $1.01B | 166.7× | $630.93M | +5.3% | $3.01M | $154.58M | $223.84M | Fair valued |
| FRBPFranklin BSP Capital Corp | $1.02B | 11.0× | $418.46M | +1.3% | $104.32M | $35.38M | $2.2B | Undervalued |
| ABUSArbutus Biopharma Corp | $1.02B | 6.6× | $14.08M | +128.2% | -$33.5M | $19.17M | $514K | Fair valued |
| HBNCHorizon Bancorp Inc | $1.02B | — | -$26.97M | -114.1% | -$150.48M | $217.95M | $222.99M | Fair valued |
| MCBSMetroCity Bankshares, Inc. | $1.02B | 12.3× | $155.63M | +10.2% | $68.53M | $266.69M | $14.13M | Fair valued |
| HRTGHeritage Insurance Holdings, Inc. | $1.02B | 4.9× | $847.33M | +3.7% | $195.59M | $587.6M | $91.83M | Undervalued |
| CCNECnb Financial Corp | $1.03B | 11.2× | $282.2M | +24.5% | $66.13M | $458.44M | $259.69M | Fair valued |
| AVTXAvalo Therapeutics, Inc. | $1.03B | — | $59K | -86.6% | -$78.26M | $85.38M | $242K | Fair valued |
| ITRNIturan Location & Control Ltd. | $1.03B | 16.0× | $359.02M | +6.8% | $57.97M | $107.55M | $8.88M | Fair valued |
| BFSTBusiness First Bancshares, Inc. | $1.03B | 11.3× | $324.71M | +19.6% | $87.86M | $575.6M | $25.21M | Fair valued |
| PXEDPhoenix Education Partners, Inc. | $1.04B | 12.9× | $950.02M | +13.7% | $115.15M | $155.02M | $121.58M | Fair valued |
| GHMGraham Corp | $1.04B | 84.9× | $245.29M | +16.9% | $12.5M | $26.95M | $6.79M | Overvalued |
| NPKNational Presto Industries Inc | $1.04B | 24.3× | $503.52M | +29.7% | $33.08M | $15.79M | $9.18M | Overvalued |
| FTHFaeth Therapeutics, Inc. | $1.04B | — | — | — | — | $26.9M | $592K | Fair valued |
| AIPArteris, Inc. | $1.04B | — | $70.58M | +22.3% | -$34.75M | $93.27M | $5.19M | Overvalued |
| LUXELuxExperience B.V. | $1.04B | 1.9× | €1.26B | +50.1% | €569.96M | €418.6M | €189.66M | Fair valued |